Multi-omics reveals the associations among the fecal metabolome, intestinal bacteria, and serum indicators in patients with hepatocellular carcinoma

doi:10.3748/wjg.v31.i15.104996

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 15

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (170)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-4) series.

Item

Count

PDF

HTML

Figures (1-7)

Tables (1-4)

Sum=145

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=13

Apr 21, 2025 (publication date) through Apr 21, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Apr 21, 2025; 31(15): 104996
Published online Apr 21, 2025. doi: 10.3748/wjg.v31.i15.104996

Full Size Figure Download Figure

Figure 2 Volcano plots of the differential metabolites and bubble plots of the Kyoto Encyclopedia of Genes and Genomes pathways. A-C: The differential metabolites of healthy control (HC) vs comprising patients with stage I and II hepatocellular carcinoma (HCC12) (A), HC vs comprising patients with stage III and IV hepatocellular carcinoma (HCC34) (B), and HCC12 vs HCC34 (C) were displayed as volcano plots; D and E: Kyoto Encyclopedia of Genes and Genomes enrichment analysis was separately performed on the MetaboAnalyst website (https://www.metaboanalyst.ca/) for the differential metabolites in the two comparisons, namely HC vs HCC12 (D) and HC vs HCC34 (E). HCC: Hepatocellular carcinoma; HCC12: Comprising patients with stage I and II hepatocellular carcinoma; HCC34: Comprising patients with stage III and IV hepatocellular carcinoma; VIP: Variable importance in projection; FC: Fold change.

Citation: Feng J, Wang JP, Hu JR, Li P, Lv P, He HC, Cheng XW, Cao Z, Han JJ, Wang Q, Su Q, Liu LX. Multi-omics reveals the associations among the fecal metabolome, intestinal bacteria, and serum indicators in patients with hepatocellular carcinoma. World J Gastroenterol 2025; 31(15): 104996
URL: https://www.wjgnet.com/1007-9327/full/v31/i15/104996.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i15.104996